TEST BANK
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
edition Woo Robinson Test Bank
Chapter 1. The Role of the Nurse Practitioner as PrescriberMultiple Choice
Identify the choice that best completes the statement or answers the question.
1. Nurse practitioner prescriptive authority is regulated by:
1. The National Council of State Boards of Nursing
2. The U.S. Drug Enforcement Administration
3. The State Board of Nursing for each state
4. The State Board of Pharmacy
2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber
include:
1. Nurses know more about Pharmacology than other prescribers because they take it
both in their basic nursing program and in their APRN program.
2. Nurses care for the patient from a holistic approach and include the patient in
decision making regarding their care.
3. APRNs are less likely to prescribe narcotics and other controlled substances.
4. APRNs are able to prescribe independently in all states, whereas a physician’s
assistant needs to have a physician supervising their practice.
3. Clinical judgment in prescribing includes:
1. Factoring in the cost to the patient of the medication prescribed
2. Always prescribing the newest medication available for the disease process
3. Handing out drug samples to poor patients
4. Prescribing all generic medications to cut costs
4. Criteria for choosing an effective drug for a disorder include:
1. Asking the patient what drug they think would work best for them
2. Consulting nationally recognized guidelines for disease management
3. Prescribing medications that are available as samples before writing a prescription
4. Following U.S. Drug Enforcement Administration guidelines for prescribing
5. Nurse practitioner practice may thrive under health-care reform because of:
1. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
2. The fact that nurse practitioners will be able to practice independently
3. The fact that nurse practitioners will have full reimbursement under health-
care reform
4. The ability to shift accountability for Medicaid to the state level
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
edition Woo Robinson Test Bank
Chapter 1. The Role of the Nurse Practitioner as Prescriber
Answer Section
MULTIPLE CHOICE
1. ANS: 3 PTS: 1
2. ANS: 2 PTS: 1
3. ANS: 1 PTS: 1
4. ANS: 2 PTS: 1
5. ANS: 1 PTS: 1
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
edition Woo Robinson Test Bank
Chapter i2. iReview iof ithe iBasic iPrinciples iof iPharmacology
iMultiple iChoice
Identify ithe ichoice ithat ibest icompletes ithe istatement ior ianswers ithe iquestion.
1. iA ipatient’s inutritional iintake iand ilaboratory iresults ireflect ihypoalbuminemia. iThis iis icritical
ito iprescribing ibecause:
1. Distribution iof idrugs ito itarget itissue imay ibe iaffected.
2. The isolubility iof ithe idrug iwill inot imatch ithe isite iof iabsorption.
3. There iwill ibe iless ifree idrug iavailable ito igenerate ian ieffect.
4. Drugs ibound ito ialbumin iare ireadily iexcreted iby ithe ikidneys.
2. iDrugs ithat ihave ia isignificant ifirst-pass i effect:
1. Must ibe igiven iby ithe ienteral i(oral) iroute ionly
2. Bypass ithe ihepatic icirculation
3. Are irapidly imetabolized iby ithe iliver iand imay ihave ilittle iif iany idesired iaction
4. Are iconverted iby ithe iliver ito imore iactive iand ifat-soluble iforms
i3. iThe iroute iof i excretion iof ia ivolatile idrug iwill ilikely ibe i the:
1. Kidneys
2. Lungs
3. Bile iand ifeces
4. Skin
4. iMedroxyprogesterone i(Depo iProvera) iis iprescribed iintramuscularly i(IM) ito icreate ia
istorage ireservoir iof ithe idrug. iStorage ireservoirs:
1. Assure ithat ithe idrug iwill ireach iits iintended itarget itissue
2. Are ithe ireason ifor igiving iloading idoses
3. Increase ithe ilength iof itime ia idrug iis iavailable iand iactive
4. Are imost icommon iin icollagen itissues
5. iThe iNP ichooses ito igive icephalexin ievery i8 ihours ibased ion iknowledge iof ithe i drug’s:
1. Propensity ito igo ito ithe itarget ireceptor
2. Biological ihalf-life
3. Pharmacodynamics
4. Safety iand iside ieffects
6. iAzithromycin idosing irequires ithat ithe ifirst iday’s idosage ibe itwice ithose iof ithe iother i4 idays iof
ithe iprescription. iThis iis iconsidered ia iloading idose. iA iloading idose:
1. Rapidly iachieves idrug ilevels iin ithe itherapeutic irange
2. Requires ifour- ito ifive-half-lives ito iattain
3. Is iinfluenced iby irenal ifunction
4. Is idirectly irelated ito ithe idrug icirculating ito ithe itarget itissues
7. iThe ipoint iin itime ion ithe idrug iconcentration icurve ithat iindicates ithe ifirst isign iof ia itherapeutic
ieffect iis ithe:
1. Minimum iadverse ieffect ilevel
2. Peak iof iaction
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
edition Woo Robinson Test Bank
Chapter 1. The Role of the Nurse Practitioner as PrescriberMultiple Choice
Identify the choice that best completes the statement or answers the question.
1. Nurse practitioner prescriptive authority is regulated by:
1. The National Council of State Boards of Nursing
2. The U.S. Drug Enforcement Administration
3. The State Board of Nursing for each state
4. The State Board of Pharmacy
2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber
include:
1. Nurses know more about Pharmacology than other prescribers because they take it
both in their basic nursing program and in their APRN program.
2. Nurses care for the patient from a holistic approach and include the patient in
decision making regarding their care.
3. APRNs are less likely to prescribe narcotics and other controlled substances.
4. APRNs are able to prescribe independently in all states, whereas a physician’s
assistant needs to have a physician supervising their practice.
3. Clinical judgment in prescribing includes:
1. Factoring in the cost to the patient of the medication prescribed
2. Always prescribing the newest medication available for the disease process
3. Handing out drug samples to poor patients
4. Prescribing all generic medications to cut costs
4. Criteria for choosing an effective drug for a disorder include:
1. Asking the patient what drug they think would work best for them
2. Consulting nationally recognized guidelines for disease management
3. Prescribing medications that are available as samples before writing a prescription
4. Following U.S. Drug Enforcement Administration guidelines for prescribing
5. Nurse practitioner practice may thrive under health-care reform because of:
1. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
2. The fact that nurse practitioners will be able to practice independently
3. The fact that nurse practitioners will have full reimbursement under health-
care reform
4. The ability to shift accountability for Medicaid to the state level
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
edition Woo Robinson Test Bank
Chapter 1. The Role of the Nurse Practitioner as Prescriber
Answer Section
MULTIPLE CHOICE
1. ANS: 3 PTS: 1
2. ANS: 2 PTS: 1
3. ANS: 1 PTS: 1
4. ANS: 2 PTS: 1
5. ANS: 1 PTS: 1
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
edition Woo Robinson Test Bank
Chapter i2. iReview iof ithe iBasic iPrinciples iof iPharmacology
iMultiple iChoice
Identify ithe ichoice ithat ibest icompletes ithe istatement ior ianswers ithe iquestion.
1. iA ipatient’s inutritional iintake iand ilaboratory iresults ireflect ihypoalbuminemia. iThis iis icritical
ito iprescribing ibecause:
1. Distribution iof idrugs ito itarget itissue imay ibe iaffected.
2. The isolubility iof ithe idrug iwill inot imatch ithe isite iof iabsorption.
3. There iwill ibe iless ifree idrug iavailable ito igenerate ian ieffect.
4. Drugs ibound ito ialbumin iare ireadily iexcreted iby ithe ikidneys.
2. iDrugs ithat ihave ia isignificant ifirst-pass i effect:
1. Must ibe igiven iby ithe ienteral i(oral) iroute ionly
2. Bypass ithe ihepatic icirculation
3. Are irapidly imetabolized iby ithe iliver iand imay ihave ilittle iif iany idesired iaction
4. Are iconverted iby ithe iliver ito imore iactive iand ifat-soluble iforms
i3. iThe iroute iof i excretion iof ia ivolatile idrug iwill ilikely ibe i the:
1. Kidneys
2. Lungs
3. Bile iand ifeces
4. Skin
4. iMedroxyprogesterone i(Depo iProvera) iis iprescribed iintramuscularly i(IM) ito icreate ia
istorage ireservoir iof ithe idrug. iStorage ireservoirs:
1. Assure ithat ithe idrug iwill ireach iits iintended itarget itissue
2. Are ithe ireason ifor igiving iloading idoses
3. Increase ithe ilength iof itime ia idrug iis iavailable iand iactive
4. Are imost icommon iin icollagen itissues
5. iThe iNP ichooses ito igive icephalexin ievery i8 ihours ibased ion iknowledge iof ithe i drug’s:
1. Propensity ito igo ito ithe itarget ireceptor
2. Biological ihalf-life
3. Pharmacodynamics
4. Safety iand iside ieffects
6. iAzithromycin idosing irequires ithat ithe ifirst iday’s idosage ibe itwice ithose iof ithe iother i4 idays iof
ithe iprescription. iThis iis iconsidered ia iloading idose. iA iloading idose:
1. Rapidly iachieves idrug ilevels iin ithe itherapeutic irange
2. Requires ifour- ito ifive-half-lives ito iattain
3. Is iinfluenced iby irenal ifunction
4. Is idirectly irelated ito ithe idrug icirculating ito ithe itarget itissues
7. iThe ipoint iin itime ion ithe idrug iconcentration icurve ithat iindicates ithe ifirst isign iof ia itherapeutic
ieffect iis ithe:
1. Minimum iadverse ieffect ilevel
2. Peak iof iaction
